Literature DB >> 34321599

IL-8 correlates with reduced baseline femoral neck bone mineral density in adults with cystic fibrosis: a single center retrospective study.

Grace Y Lam1, Sameer Desai2, Joey Fu3, Xun Yang Hu3, Jiah Jang4, Azita Goshtasebi5,6, Shirin Kalyan5, Bradley S Quon7,8.   

Abstract

Cystic fibrosis (CF) is a multi-system disease that is characterized by lung disease due to recurrent airway infection and inflammation. Endocrine complications, such as CF bone disease (CFBD), are increasingly identified as patients are living longer. The cause of CFBD is multifactorial with chronic systemic inflammation theorized to be a contributing factor. Thus, we attempted to identify inflammatory biomarkers that are associated with CFBD. We conducted a retrospective observational study of 56 adult patients with CF with an average percentage predictive forced expiratory volume in one second (ppFEV1) of 73.7% (standard deviation: 30.0) who underwent baseline serum analysis for osteoprotegerin (OPG) and pro-inflammatory biomarkers (IL-1β, IL-6, IL-8 and TNF-α), and had repeated dual-energy x-ray absorptiometry (DXA) scans separated by at least 2 years to examine correlations between serum biomarkers and bone mineral density (BMD) measurements. Univariate linear regression model analysis demonstrated that serum IL-1β and IL-8, but not other pro-inflammatory markers, were negatively correlated with baseline BMD results. However, after accounting for confounding variables, only the relationship between IL-8 and left femoral neck BMD remained statistically significant. Additionally, IL-8 level was associated with BMD decline over time. These results suggest that IL-8 might play a unique role in the pathophysiology of CFBD relative to other pro-inflammatory cytokines but further study is warranted before firm conclusions can be made.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34321599     DOI: 10.1038/s41598-021-94883-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  13 in total

1.  Factors associated with low bone mineral density in patients with cystic fibrosis.

Authors:  Shahid Sheikh; Susan Gemma; Alpa Patel
Journal:  J Bone Miner Metab       Date:  2014-03-16       Impact factor: 2.626

2.  Cystic fibrosis and bone disease: defective osteoblast maturation with the F508del mutation in cystic fibrosis transmembrane conductance regulator.

Authors:  Frédéric Velard; Martial Delion; Carole Le Henaff; Christine Guillaume; Sophie Gangloff; Jacky Jacquot; Olivier Tabary; Lhousseine Touqui; Françoise Barthes; Isabelle Sermet-Gaudelus
Journal:  Am J Respir Crit Care Med       Date:  2014-03-15       Impact factor: 21.405

Review 3.  Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.

Authors:  J Jacquot; M Delion; S Gangloff; J Braux; F Velard
Journal:  Osteoporos Int       Date:  2015-10-02       Impact factor: 4.507

4.  Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis.

Authors:  R M Aris; A R Stephens; D A Ontjes; A Denene Blackwood; R K Lark; M B Hensler; I P Neuringer; G E Lester
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

5.  Bone demineralization in cystic fibrosis: evidence of imbalance between bone formation and degradation.

Authors:  G I Baroncelli; F De Luca; G Magazzú; T Arrigo; C Sferlazzas; C Catena; S Bertelloni; G Saggese
Journal:  Pediatr Res       Date:  1997-03       Impact factor: 3.756

6.  Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone.

Authors:  Louis Le Heron; Christine Guillaume; Frédéric Velard; Julien Braux; Lhousseine Touqui; Sandra Moriceau; Isabelle Sermet-Gaudelus; Dominique Laurent-Maquin; Jacky Jacquot
Journal:  J Cyst Fibros       Date:  2009-12-14       Impact factor: 5.482

7.  Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls.

Authors:  Ristan M Greer; Helen M Buntain; Julia M Potter; Claire E Wainwright; Joseph C Wong; Peter K O'Rourke; Paul W Francis; Scott C Bell; Jennifer A Batch
Journal:  Osteoporos Int       Date:  2003-04-08       Impact factor: 4.507

Review 8.  The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis.

Authors:  J Paccou; N Zeboulon; C Combescure; L Gossec; B Cortet
Journal:  Calcif Tissue Int       Date:  2009-12-01       Impact factor: 4.333

Review 9.  [Insights into cystic fibrosis-related bone disease].

Authors:  C Braun; J Bacchetta; P Reix
Journal:  Arch Pediatr       Date:  2016-06-23       Impact factor: 1.180

Review 10.  Management of comorbidities in older patients with cystic fibrosis.

Authors:  Barry J Plant; Christopher H Goss; William D Plant; Scott C Bell
Journal:  Lancet Respir Med       Date:  2013-03-19       Impact factor: 30.700

View more
  1 in total

1.  The Positive Association of Plasma Levels of Vitamin C and Inverse Association of VCAM-1 and Total Adiponectin with Bone Mineral Density in Subjects with Diabetes.

Authors:  Sushil K Jain; William E McLean; Christopher M Stevens; Richa Dhawan
Journal:  Nutrients       Date:  2022-09-20       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.